Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.

Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. - Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019140

Enrollment

100

Registered

2015-09-28

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema (especially subclinical and early-stage) and lymphatic disease

Interventions

Indocyanine green (ICG) lymphography and Lymphatic venous anastomosis (Modified Campisi&#39

s LVA for subclinical and early-stage lymphedema) Indocyanine green (ICG) lymphography and lymph node transfer Indocyanine green (ICG) lymphography and liposuction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All Subjects included in this study are lymphedema and lymphatic disease patients undergoing surgical treatment at our department who have been fully informed of all clinical tests, questionnaires, surgical treatments, and the purpose and analysis of this study and have all consented in writing. No age restriction and exclusion criteria were set.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness); echogram, CT, MRI, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations. We analyze patient pre-operation and every 6 months after operation.	—

Measure

Time frame

Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness); echogram, CT, MRI, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations. We analyze patient pre-operation and every 6 months after operation.

—

Secondary

Measure	Time frame
Diagnostic imaging for lymph node. And NECST classification for Afferent and Efferent lymph vessels.	—

Countries

Japan

Contacts

Public ContactYoshinori Shimizu

Saiseikai Kawaguchi General Hospital Financial and legal department

zaimuhoumu@saiseikai.gr.jp048-253-1551

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026